Advisor – Quality Audit and Compliance (Controlled Substances) at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Comprehensive knowledge of applicable regulations, particularly US DEA regulations for Controlled Substances (CS), and GxP compliance
  • Technical knowledge and training to meet auditing responsibilities, including interpretation of Lilly standards, regulations, regulatory guidance, and industry standards
  • Ability to interpret regulatory and quality standard requirements for business processes and provide guidance
  • Skills in building and maintaining relationships with regulatory authorities
  • Capability to maintain Power of Attorney documentation, manage DEA registrations, sign DEA Form 222, and complete DEA online reporting

Responsibilities

  • Serve as Global SSS/CS Process Owner, leading or participating in preparation and review of standards, policies, procedures, and guidelines for Quality, SSS, and CS requirements
  • Review proposed CS regulations (particularly US DEA), collaborate with legal and industry groups on comments, own and maintain Lilly Quality Standard 303, and handle risk assessment for SSS designation
  • Build and maintain relationships with regulatory authorities; facilitate and host inspections from US DEA, Indiana Board of Pharmacy, and other state CS agencies
  • Maintain Power of Attorney documentation to manage DEA registrations, sign DEA Form 222, and complete required online reporting via DEA website
  • Provide regulatory interpretation and guidance across product lifecycle for SSS and CS materials (API, drug product, finished product, samples, reference standards)
  • Develop or support corrective and preventive actions (CAPAs) to address gaps in SSS/CS compliance processes
  • Escalate compliance issues promptly and appropriately
  • Ensure adherence to applicable quality standards, manuals, policies, procedures, and tools
  • Lead or participate in planning, scheduling, preparing, conducting, escalating, and reporting audits, assessments, and due diligences of GMP Operations and SSS/CS to assess compliance

Skills

Key technologies and capabilities for this role

GxP ComplianceQuality AuditingControlled SubstancesDEA RegulationsRisk AssessmentRegulatory InterpretationInternal AuditsExternal AuditsQuality AssurancePharmaceutical Compliance

Questions & Answers

Common questions about this position

What is the employment type for this position?

This is a full-time position.

Is this role remote or does it require working from a specific location?

This information is not specified in the job description.

What are the key responsibilities or skills needed for the Advisor – Quality Audit and Compliance role?

The role involves serving as Global SSS/CD Process Owner, leading preparation and review of standards for Quality, SSS, and CS requirements, building relationships with regulatory authorities, facilitating DEA inspections, and maintaining Power of Attorney documentation for DEA registrations.

What is the company culture like at Eli Lilly?

Eli Lilly unites caring with discovery to make life better for people around the world, puts people first, and seeks determined individuals; the GQAAC division operates as a valued business partner with a proactive approach to improving quality and regulatory compliance.

What makes a strong candidate for this Quality Audit and Compliance Advisor position?

Strong candidates will have expertise in GxP compliance, controlled substances regulations (especially US DEA), experience with regulatory interpretations across the product lifecycle, auditing skills, and the ability to build relationships with regulatory authorities.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI